Calamos Advisors

Calamos Advisors’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

Calamos Advisors’s Portfolio ORIAU Stock Details ORIAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-375,000	Closed	-$3.7M	–	1482
2022 Q2	$3.7M	Hold	375,000	–	–	0.02%	798
2022 Q1	$3.66M	Hold	375,000	–	–	0.01%	797
2021 Q4	$3.71M	Hold	375,000	–	–	0.01%	786
2021 Q3	$3.75M	Hold	375,000	–	–	0.02%	682
2021 Q2	$3.79M	Buy	+375,000	New	+$3.78M	0.02%	626

Other funds holding ORIAU

JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return

Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return